A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
Clinical trial NCT00942578 · COMPLETED
Trial details
- NCT number
- NCT00942578
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-16
- Primary completion
- 2017-07-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.